Retrospective Analysis of Efficacy and Safety of Tocilizumab Treatment in Patients with Severe Systemic-Onset Juvenile Idiopathic Arthritis Followed for 12 Months

Table 4

Causes and schedule of tocilizumab withdrawal.

Causes of withdrawal	Schedule of withdrawal; (months)	Patients, 𝑛
Insufficient efficacy	3–6	3
Relapses	4–12	7
Anaphylactic reaction	1	1
Disease remission	11	1
Crohn’s disease	6	1
Refusal of parents	1	1